Sin3a acts through a multi-gene module to regulate invasion in Drosophila and human tumors

Oncogene

Volumn 32, Issue 26, 2013, Pages 3184-3197

  Das, T K ^a   Sangodkar, J ^a   Negre, N ^b   Narla, G ^a   Cagan, R L ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Drosophila; Ret; Rho; Sin3a; Src; wingless

Indexed keywords

ACTIN; BETA CATENIN; HISTONE DEACETYLASE; PROTEIN RET; PROTEIN TYROSINE KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR SIN3A;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOGENESIS; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; DROSOPHILA; GENE; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION; WNT SIGNALING PATHWAY;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; DROSOPHILA; DROSOPHILA PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-RET; REPRESSOR PROTEINS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSCRIPTIONAL ACTIVATION; WNT1 PROTEIN;

MAMMALIA;

EID: 84879693496     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.326     Document Type: Article

References (67)

1. Lafon-Hughes L, Di Tomaso MV, Mendez-Acuna L, Martinez-Lopez W. Chromatinremodelling mechanisms in cancer. Mutat Res. 2008; 658: 191-214.
2. Minucci S, Pelicci PG. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 2006; 6: 38-51.
3. Janic A, Mendizabal L, Llamazares S, Rossell D, Gonzalez C. Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila. Science 2010; 330: 1824-1827.
4. Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO et al. The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 2010; 468: 1105-1109.
5. Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature 2012; 481: 329-334.
6. Hassig CA, Fleischer TC, Billin AN, Schreiber SL, Ayer DE. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 1997; 89: 341-347.
7. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE et al. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 1997; 89: 373-380.
8. Dannenberg JH, David G, Zhong S, van der Torre J, Wong WH, Depinho RA. mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev 2005; 19: 1581-1595.
9. Grimes JA, Nielsen SJ, Battaglioli E, Miska EA, Speh JC, Berry DL et al. The corepressor mSin3A is a functional component of the REST-CoREST repressor complex. J Biol Chem 2000; 275: 9461-9467.
10. Pile LA, Spellman PT, Katzenberger RJ, Wassarman DA. The SIN3 deacetylase complex represses genes encoding mitochondrial proteins: implications for the regulation of energy metabolism. J Biol Chem 2003; 278: 37840-37848.
11. Alland L, Muhle R, Hou Jr H , Potes J, Chin L, Schreiber-Agus N et al. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 1997; 387: 49-55.
12. Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L et al. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene 1996; 12: 1165-1172.
13. David G, Grandinetti KB, Finnerty PM, Simpson N, Chu GC, Depinho RA. Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation. Proc Natl Acad Sci USA. 2008; 105: 4168-4172.
14. Lai A, Kennedy BK, Barbie DA, Bertos NR, Yang XJ, Theberge MC et al. RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest. Mol Cell Biol 2001; 21: 2918-2932.
15. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13: 2490-2501.
16. Zhang Y, Akinmade D, Hamburger AW. The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription. Nucleic Acids Res 2005; 33: 6024-6033.
17. Hurst DR, Xie Y, Edmonds MD, Welch DR. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clin Exp Metastasis 2009; 26: 89-96.
18. Samant RS, Debies MT, Hurst DR, Moore BP, Shevde LA, Welch DR. Suppression of murine mammary carcinoma metastasis by the murine ortholog of breast cancer metastasis suppressor 1 (Brms1). Cancer Lett 2006; 235: 260-265.
19. Meehan WJ, Samant RS, Hopper JE, Carrozza MJ, Shevde LA, Workman JL et al. Breast cancer metastasis suppressor 1 (BRMS1) forms complexes with retinoblastoma- binding protein 1 (RBP1) and the mSin3 histone deacetylase complex and represses transcription. J Biol Chem 2004; 279: 1562-1569.
20. Farias EF, Petrie K, Leibovitch B, Murtagh J, Chornet MB, Schenk T et al. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells. Proc Natl Acad Sci USA 2010; 107: 11811-11816.
21. Read RD, Goodfellow PJ, Mardis ER, Novak N, Armstrong JR, Cagan RLA. Drosophila model of multiple endocrine neoplasia type 2. Genetics 2005; 171: 1057-1081.
22. Plaza-Menacho I, Burzynski GM, de Groot JW, Eggen BJ, Hofstra RM. Current concepts in RET-related genetics, signaling and therapeutics. Trends Genet 2006; 22: 627-636.
23. Vidal M, Larson DE, Cagan RL. Csk-deficient boundary cells are eliminated from normal Drosophila epithelia by exclusion, migration, and apoptosis. Dev Cell 2006; 10: 33-44.
24. Ellison-Zelski SJ, Alarid ET. Maximum growth and survival of estrogen receptoralpha positive breast cancer cells requires the Sin3A transcriptional repressor. Mol Cancer 2010; 9: 263.
25. Nascimento EM, Cox CL, Macarthur S, Hussain S, Trotter M, Blanco S et al. The opposing transcriptional functions of Sin3a and c-Myc are required to maintain tissue homeostasis. Nat Cell Biol 2011; 13: 1395-1405.
26. Moreno-Bueno G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-6969.
27. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-454.
28. Negre N, Brown CD, Ma L, Bristow CA, Miller SW, Wagner U et al. A cis-regulatory map of the Drosophila genome. Nature 2011; 471: 527-531.
29. van Oevelen C, Wang J, Asp P, Yan Q, Kaelin Jr. WG , Kluger Y et al. A role for mammalian Sin3 in permanent gene silencing. Mol Cell 2008; 32: 359-370.
30. Kouzarides T. Chromatin modifications and their function. Cell 2007; 128: 693-705.
31. Margueron R, Trojer P, Reinberg D. The key to development: interpreting the histone code? Curr Opin Genet Dev 2005; 15: 163-176.
32. Cooper JA, Gould KL, Cartwright CA, Hunter T. Tyr527 is phosphorylated in pp60csrc: implications for regulation. Science 1986; 231: 1431-1434.
33. Iwashita T, Asai N, Murakami H, Matsuyama M, Takahashi M. Identification of tyrosine residues that are essential for transforming activity of the ret protooncogene with MEN2A or MEN2B mutation. Oncogene 1996; 12: 481-487.
34. Songyang Z, Carraway 3rd KL , Eck MJ, Harrison SC, Feldman RA, Mohammadi M et al. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 1995; 373: 536-539.
35. Read RD, Bach EA, Cagan RL. Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways. Mol Cell Biol 2004; 24: 6676-6689.
36. Hasegawa T, Enomoto A, Kato T, Kawai K, Miyamoto R, Jijiwa M et al. Roles of induced expression of MAPK phosphatase-2 in tumor development in RET-MEN2A transgenic mice. Oncogene 2008; 27: 5684-5695.
37. Uhlirova M, Bohmann D. JNK- and Fos-regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila. EMBO J. 2006; 25: 5294-5304.
38. Teng DH, Perry 3rd WL , Hogan JK, Baumgard M, Bell R, Berry S et al. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor. Cancer Res 1997; 57: 4177-4182.
39. Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature 2012; 486: 346-352.
40. Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II et al. Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing peroxisome proliferator-activated receptor gamma2 expression. Mol Cell Biol 2011; 31: 4270-4285.
41. Geuking P, Narasimamurthy R, Lemaitre B, Basler K, Leulier F. A non-redundant role for Drosophila Mkk4 and hemipterous/Mkk7 in TAK1-mediated activation of JNK. PLoS ONE 2009; 4: e7709.
42. Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE et al. Beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 2011; 20: 741-754.
43. Parri M, Chiarugi P. Rac and Rho GTPases in cancer cell motility control. Cell Commun Signal 2010; 8: 23.
44. Duman-Scheel M, Johnston LA, Du W. Repression of dMyc expression by Wingless promotes Rbf-induced G1 arrest in the presumptive Drosophila wing margin. Proc Natl Acad Sci USA 2004; 101: 3857-3862.
45. Blauwkamp TA, Chang MV, Cadigan KM. Novel TCF-binding sites specify transcriptional repression by Wnt signalling. EMBO J 2008; 27: 1436-1446.
46. Castellone MD, De Falco V, Rao DM, Bellelli R, Muthu M, Basolo F et al. The betacatenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. Cancer Res 2009; 69: 1867-1876.
47. Polette M, Mestdagt M, Bindels S, Nawrocki-Raby B, Hunziker W, Foidart JM et al. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007; 185: 61-65.
48. Lilien J, Balsamo J. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 2005; 17: 459-465.
49. Schmalhofer O, Brabletz S, Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009; 28: 151-166.
50. Luo W, Peterson A, Garcia BA, Coombs G, Kofahl B, Heinrich R et al. Protein phosphatase 1 regulates assembly and function of the beta-catenin degradation complex. EMBO J 2007; 26: 1511-1521.
51. Pile LA, Schlag EM, Wassarman DA. The SIN3/RPD3 deacetylase complex is essential for G(2) phase cell cycle progression and regulation of SMRTER corepressor levels. Mol Cell Biol 2002; 22: 4965-4976.
52. Suzuki H, Ouchida M, Yamamoto H, Yano M, Toyooka S, Aoe M et al. Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer. Lung Cancer 2008; 59: 24-31.
53. Sancho R, Nateri AS, de Vinuesa AG, Aguilera C, Nye E, Spencer-Dene B et al. JNK signalling modulates intestinal homeostasis and tumourigenesis in mice. EMBO J 2009; 28: 1843-1854.
54. DiFeo A, Feld L, Rodriguez E, Wang C, Beer DG, Martignetti JA et al. A functional role for KLF6-SV1 in lung adenocarcinoma prognosis and chemotherapy response. Cancer Res 2008; 68: 965-970.
55. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
56. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320.
57. Cadigan KM. TCFs and Wnt/beta-catenin signaling: more than one way to throw the switch. Curr Top Dev Biol 2012; 98: 1-34.
58. Foglietti C, Filocamo G, Cundari E, De Rinaldis E, Lahm A, Cortese R et al. Dissecting the biological functions of Drosophila histone deacetylases by RNA interference and transcriptional profiling. J Biol Chem 2006; 281: 17968-17976.
59. Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS, Costantini F. C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J 2000; 19: 612-622.
60. Sangodkar J, Shi J, DiFeo A, Schwartz R, Bromberg R, Choudhri A et al. Functional role of the KLF6 tumour suppressor gene in gastric cancer. Eur J Cancer 2009; 45: 666-676.
61. Brachmann CB, Jassim OW, Wachsmuth BD, Cagan RL. The Drosophila bcl-2 family member dBorg-1 functions in the apoptotic response to UV-irradiation. Curr Biol 2000; 10: 547-550.
62. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci USA 2001; 98: 13784-13789.
63. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639-1647.
64. Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J et al. Gene expression patterns in human liver cancers. Mol Biol Cell 2002; 13: 1929-1939.
65. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-752.
66. Higgins JP, Shinghal R, Gill H, Reese JH, Terris M, Cohen RJ et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol 2003; 162: 925-932.
67. Chen X, Leung SY, Yuen ST, Chu KM, Ji J, Li R et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003; 14: 3208-3215.